Skip to content

Obesity-associated ophthalmopathy study

Obesity-associated ophthalmopathy study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034371
Enrollment
Unknown
Registered
2020-07-03
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

control group:Nil

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 7 to 8 years; 2. 40 children diagnosed with obesity and an equal number of age- and sex-matched healthy control subjects were recruited; 3. Subjects and the parents or legal guardians of all participants voluntarily joined the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The exclusion criteria were the presence of amblyopia, nystagmus, retinal disease, hypermetropia exceeding 2 D, myopia and astigmatism exceeding 1 D, glaucoma, intraocular inflammation, strabismus, elevated intraocular pressure > 21 mmHg and media opacity, such as corneal disease or cataract. 2. Patients with a history of prematurity, neurologic disease, ocular trauma, ocular surgery or systemic conditions that could alter the microvasculature (including diabetes, hypertension, cardiovascular disease, and renal disease) were excluded. 3. Additionally, patients with head, neck, or other injuries preventing proper positioning or with an inability to maintain retinal fixation on a specified target (owing to poor vision or cooperation) were excluded.

Design outcomes

Primary

MeasureTime frame
retinal thickness;foveal avascular zone;vessel density;Anthropometric measurements;

Secondary

MeasureTime frame
visual acuity;refraction diopter;axial length;intraocular pressure;

Countries

China

Contacts

Public ContactHu Liu

The First Affiliated Hospital with Nanjing Medical University

liuhu@njmu.edu.cn+86 25-68136470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026